<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.0//EN" "ep-patent-document-v1-0.dtd"><ep-patent-document id="EP04812312A1" file="04812312.9" lang="en" country="EP" doc-number="1699783" kind="A1" date-publ="20060913" status="n" dtd-version="ep-patent-document-v1-1"><SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILT..FIRO..CY..TRBGCZEEHUPLSK....IS..........</B001EP><B003EP>*</B003EP><B005EP>X</B005EP><B007EP>DIM360 (Ver 1.5  21 Nov 2005) -  1100000/0 1710000/0</B007EP></eptags></B000><B100><B110>1699783</B110><B130>A1</B130><B140><date>20060913</date></B140><B190>EP</B190></B100><B200><B210>04812312.9</B210><B220><date>20041215</date></B220><B240><B241><date>20060724</date></B241></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>03380303</B310><B320><date>20031222</date></B320><B330><ctry>EP</ctry></B330><B310>539748 P</B310><B320><date>20040128</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>20060913</date><bnum>200637</bnum></B405><B430><date>20060913</date><bnum>200637</bnum></B430></B400><B500><B510EP><classification-ipcr sequence="1"><text>C07D 409/14        20060101AFI20050725BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>C07D 401/04        20060101ALI20050725BHEP        </text></classification-ipcr><classification-ipcr sequence="3"><text>C07D 213/82        20060101ALI20050725BHEP        </text></classification-ipcr><classification-ipcr sequence="4"><text>C07D 213/78        20060101ALI20050725BHEP        </text></classification-ipcr><classification-ipcr sequence="5"><text>A61K  31/4427      20060101ALI20050725BHEP        </text></classification-ipcr><classification-ipcr sequence="6"><text>A61K  31/44        20060101ALI20050725BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>ANTAGONISTEN DES OPIOIDREZEPTORS</B542><B541>en</B541><B542>OPIOID RECEPTOR ANTAGONISTS</B542><B541>fr</B541><B542>ANTAGONISTES DE RECEPTEUR D'OPIOIDES</B542></B540></B500><B700><B710><B711><snm>ELI LILLY AND COMPANY</snm><iid>00204942</iid><irf>x16440ep</irf><adr><str>Lilly Corporate Center</str><city>Indianapolis, Indiana 46285</city><ctry>US</ctry></adr></B711></B710><B720><B721><snm>DE LA TORRE, GARCIA Marta,
Lilly, S. A.</snm><adr><str>Avenida de la Industria 30</str><city>E-28108 Alcobendas Madrid</city><ctry>ES</ctry></adr></B721><B721><snm>DIAZ BUEZO, Nuria,
Lilly, S. A.</snm><adr><str>Avenida de la Industria 30</str><city>E-28108 Alcobendas Madrid</city><ctry>ES</ctry></adr></B721><B721><snm>JADHAV, Prabhakar, Kondaji</snm><adr><str>7422 Fox Hollow Ridge</str><city>Zionsville, Indiana 46077</city><ctry>US</ctry></adr></B721><B721><snm>MITCH, Charles, Howard</snm><adr><str>3210 Grove Parkway</str><city>Columbus, Indiana 47203</city><ctry>US</ctry></adr></B721><B721><snm>PEDREGAL TERCERO, Concepcion,
Lilly, S. A.</snm><adr><str>Avenida de la Industria 30</str><city>E-28108 Alcobendas Madrid</city><ctry>ES</ctry></adr></B721></B720><B740><B741><snm>Burnside, Ivan John</snm><iid>00091031</iid><adr><str>Eli Lilly and Company Limited 
Lilly Research Centre 
Erl Wood Manor</str><city>Windlesham, Surrey GU20 6PH</city><ctry>GB</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>TR</ctry></B840><B860><B861><dnum><anum>US2004039766</anum></dnum><date>20041215</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2005066164</pnum></dnum><date>20050721</date><bnum>200529</bnum></B871></B870></B800></SDOBI></ep-patent-document>